RxDoctor Payments Data

Ashlee Godshalk Ruggles, MD

Colon & Rectal Surgery · Pennington, NJNPI 1841558079

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (45.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 96.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $25,727 and has fallen 56.2% since, to $11,267 in 2025. Among colon & rectal surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,626in general payments, 2019–2025

Across 111 payments — averaging $393.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$42K
  • Histosonics, Inc.$724
  • Boston Scientific$231
  • Covidien LP$97
  • Davol Inc.$90
  • Romark Laboratories, LC$59
  • plus $320 from 9 others

What the payments were for

  • Speaking & faculty fees$10,00023%
  • Travel & lodging$9,85823%
  • Food & beverage$4,0819%
  • Education$19,65045%
  • Gifts$370%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,626 in reported general payments places this provider in the 95th percentile of 86 colon & rectal surgery providers in New Jersey.

See all colon & rectal surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$103,477
Medicare patients
155
Services billed
380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin Sulfate23$121
Metronidazole25$30

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Pennington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →